Semaglutide drops that Kidney Disease risk by a quarter! (UK Daily Mail)

Hey everyone — as clinic director, this is the kind of study that makes my week. Quick summary, full article at the bottom.

A major trial found that semaglutide reduces the risk of serious kidney outcomes — including kidney disease progression and kidney-related death — by roughly 24–25% in patients with diabetes and chronic kidney disease. That's not a marginal effect. That's a quarter of the risk, gone.

Here's why this matters beyond the headline. Kidney disease, heart disease, diabetes, and obesity aren't separate problems — they're one tangled metabolic mess. High blood sugar damages the kidneys' filtering units over time; about a third of people with diabetes develop chronic kidney disease. Until recently, the options for changing that trajectory were limited.

What this study adds to the picture: a medication that improves blood sugar control AND reduces weight AND calms inflammation turns out to protect the kidneys too. It's the same converging pattern we keep seeing across the GLP-1 research — heart, liver, brain, joints, and now kidneys all moving in the right direction from the same mechanism.

We see the clinic-level version of this: patients come in for weight, and the improvements that follow go way past the scale. Blood pressure, energy, mobility — the whole system responds when you treat the metabolic root.

If kidney disease runs in your family and you're carrying extra weight, this research is worth a conversation with us.

-Daryl

Book a FREE consult now <- Click There!

www.pnwmedicalgroup.com

Puyallup: 253-340-2270

Federal Way: 253-363-8877